Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspase 4 like, pseudogene (CASP4LP), also referred to as CASP17P or caspase 17 pseudogene, is a non-coding genomic sequence related by sequence similarity to caspase family genes but does not encode a functional enzyme or receptor. Unlike functional caspases such as caspase-4 (CASP4), which have established roles in apoptosis and inflammation, this pseudogene does not produce a protein product and is not a therapeutic target or a biomarker, nor implicated in disease or drug action. It should not be confused with the functional CASP4 gene, which encodes a cysteine protease involved in inflammatory cell death and signaling pathways[1][2][3]. This entry is not a therapeutic target, and no existing drug interactions, mechanisms of action, biomarker roles, or safety concerns are attributed to it. Its inclusion in target lists may indicate a need to review data sources for accuracy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase 4 like, pseudogene (CASP4LP).